# A Pharmacoeconomic Study Comparing the Use of Mycophenolate Mofetil or Cyclophosphamide as Induction Therapy in Lupus Nephritis Patients in Egypt

> **NCT05195086** · — · COMPLETED · sponsor: **Nada Magdy Mansour** · enrollment: 122 (actual)

## Conditions studied

- Lupus Nephritis

## Interventions

- **DRUG:** endoxan
- **DRUG:** cellcept

## Key facts

- **NCT ID:** NCT05195086
- **Lead sponsor:** Nada Magdy Mansour
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-01
- **Primary completion:** 2020-01-01
- **Final completion:** 2021-06-05
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2022-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05195086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05195086, "A Pharmacoeconomic Study Comparing the Use of Mycophenolate Mofetil or Cyclophosphamide as Induction Therapy in Lupus Nephritis Patients in Egypt". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05195086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*